Congratulations! At the Annual Scientific Symposium of the Fondation Maladies Rares, the Alnylam was given to Christine Labreze and François Moisan (Team 05 - Translational research in cutaneous oncology and rare skin diseases - TRIO2), for their project "Interfering RNA approach targeting the mutation of...
Visit of our future premises by a delegation of our unit. The new "Research Building" is under construction by the University of Bordeaux on the Carreire site. It will house 7 of our 11 teams.
Read the article written by Candice Ménégon for the SBM Department on the recent publication of Team 10 - Normal and Leukemic Hematopoietic Stem Cells, directed by Jean-Max Pasquet. Targeting autophagy and hematologic mobilization in FLT3-ITD acute myeloid leukemia (1/3 of patients) decreases repopulation capacity...
In the context of the awarding of the title Honoris Causa to Michel L. Tremblay (Goodman Cancer Institute, McGill University, Montreal, Quebec, Canada) by the University of Bordeaux (May 10 at 5:00 pm), Andreas Bikfalvi and the researchers of the unit are organizing a...
Michel L. tremblay and Martin J. Blaser were awarded the title of Doctor Honoris Causa by Dean Lewis, president of the University of Bordeaux after their praises by Andréas Bikfalvi (team 1) and Philippe Lehours (team 4) respectively. Honoris Causa The title of Doctor Honoris...
During the Scientific Day of the Life and Health Sciences Doctoral School, the Monique Garnier-Semancik 2022 Thesis Prize was awarded to Julian Boutin for the excellence of his research work on "Securing gene therapy by CRISPR-Cas9 in red blood cell pathologies". Julian did his thesis...
Result of the photo contest realized at the beginning of 2022 within BRIC
The first CRISPR and Translational Medicine Congress was held on March 31 and April 1st, 2022 in Bordeaux. CRISPR is one of the most powerful discoveries of the last decade and the scientific program of the congress is organized in six sessions dealing with major...
Lornella Seeneevassen (team 4, C. Varon) brilliantly defended her thesis. Subject: « Targeting Hippo pathway in gastric cancer stem cells »
Aurélie Bedel, MCU-PH team 8 Biotherapies Genetics and Oncology has defended her HDR (Habilitation to Supervise Research) on the subject "Gene therapy: from effectiveness to safety". The challenge: the supervision of future theses!
The Order of Academic Palms has distinguished this year at the University of Bordeaux 20 knights, 5 officers and 2 commanders. Congratulations to Pr. Martin Teichmann, leader of team 07 - Targeting Transcription in Breast Cancer, who has been awarded the Chevalier des Palmes académiques....
Study published in December 2021 in the journal Communications Biology by Team 06- MIRCADE (Methods and Innovations for Research in Childhood Cancers), head by Christophe Grosset "Deciphering tumour tissue organization by 3D electron microscopy and machine learning" 👉 article : de Senneville, Baudouin Denis et...
